• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于F-FDG PET/CT参数、临床病理特征及生化指标评估三阴性乳腺癌的预后危险因素

Evaluation of prognostic risk factors of triple-negative breast cancer with F-FDG PET/CT parameters, clinical pathological features and biochemical indicators.

作者信息

Zhu Lei, Yang Xin, Zhang Jiying, Wang Shuling, Wang Yulong, Wan Xing, Zhu Xiang, Song Xiuyu, Tong Zhongsheng, Yang Meng, Zhao Weipeng

机构信息

Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Department of Breast Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

出版信息

Front Cell Dev Biol. 2024 Sep 4;12:1421981. doi: 10.3389/fcell.2024.1421981. eCollection 2024.

DOI:10.3389/fcell.2024.1421981
PMID:39296933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408346/
Abstract

INTRODUCTION

Breast cancer is a heterogeneous disease comprising various molecular subtypes, including Luminal A, Luminal B, human epidermal growth factor receptor-2 (HER2) positive, and triple negative types, each with distinct biological characteristics and behaviors. Triple negative breast cancer (TNBC) remains a particularly challenging subtype worldwide. Our study aims to evaluate whether Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (F-FDG PET/CT) parameters, clinical pathological features, and biochemical indicators serve as prognostic risk factors for TNBC. Additionally, we explore correlations between biochemical indicators and F-FDG PET/CT parameters.

METHODS

We conducted a retrospective analysis of 95 TNBC patients who underwent preoperative F-FDG PET/CT examinations at Tianjin Medical University Cancer Institute and Hospital from 2013 to 2018. Collected data included F-FDG PET/CT parameters, clinical and pathological features, and biochemical indicators. We used Kaplan-Meier survival analysis and multivariate Cox regression analysis to evaluate associations between F-FDG PET/CT parameters/biochemical indicators and disease free survival (DFS)/overall survival (OS). The log-rank test determined significant differences in survival curves, and the Spearman correlation coefficient analyzed correlations between quantitative variables. Visualization and analysis were performed using R packages.

RESULTS

Among 95 TNBC patients, mean standardized uptake value (SUV) was significantly correlated with DFS. Fasting blood glucose (FBG), α- L-fucosylase (AFU) and Creatine kinase (CK) were independent predictors of DFS, while Precursor albumin (PALB) and CK were independent predictors of OS. FBG showed correlations with SUV and SUV, and CK was correlated with peak standardized uptake value (SUV). Our results indicated that F-FDG PET/CT parameters and biochemical indicators may constitute a new prognostic model for TNBC patients post-surgery.

DISCUSSION

We found that SUV, FBG, AFU and CK are predictive factors for DFS in TNBC patients post-surgery, while PALB and CK are predictive factors for OS, which prompts us to pay more attention to these indicators in clinical practice. Also F-FDG PET/CT parameters and biochemical indicators have potential utility in constituting a new prognostic model for TNBC patients post-surgery.

摘要

引言

乳腺癌是一种异质性疾病,包含多种分子亚型,包括腔面A型、腔面B型、人表皮生长因子受体2(HER2)阳性型和三阴性型,每种亚型都具有独特的生物学特征和行为。三阴性乳腺癌(TNBC)在全球范围内仍然是一种特别具有挑战性的亚型。我们的研究旨在评估氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)参数、临床病理特征和生化指标是否可作为TNBC的预后危险因素。此外,我们还探讨了生化指标与F-FDG PET/CT参数之间的相关性。

方法

我们对2013年至2018年在天津医科大学肿瘤医院接受术前F-FDG PET/CT检查的95例TNBC患者进行回顾性分析。收集的数据包括F-FDG PET/CT参数、临床和病理特征以及生化指标。我们使用Kaplan-Meier生存分析和多变量Cox回归分析来评估F-FDG PET/CT参数/生化指标与无病生存期(DFS)/总生存期(OS)之间的关联。对数秩检验确定生存曲线的显著差异,Spearman相关系数分析定量变量之间的相关性。使用R软件包进行可视化和分析。

结果

在95例TNBC患者中,平均标准化摄取值(SUV)与DFS显著相关。空腹血糖(FBG)、α-L-岩藻糖苷酶(AFU)和肌酸激酶(CK)是DFS的独立预测因素,而前白蛋白(PALB)和CK是OS的独立预测因素。FBG与SUV和最大标准化摄取值(SUVmax)相关,CK与峰值标准化摄取值(SUVpeak)相关。我们的结果表明,F-FDG PET/CT参数和生化指标可能构成TNBC患者术后的一种新的预后模型。

讨论

我们发现SUV、FBG、AFU和CK是TNBC患者术后DFS的预测因素,而PALB和CK是OS的预测因素,这促使我们在临床实践中更加关注这些指标。此外,F-FDG PET/CT参数和生化指标在构成TNBC患者术后的新预后模型方面具有潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/38240876de58/fcell-12-1421981-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/95b8b63f33f7/fcell-12-1421981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/5a7aa34201f7/fcell-12-1421981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/225aaff2c3a3/fcell-12-1421981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/07103de4ae03/fcell-12-1421981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/3464765fb612/fcell-12-1421981-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/38240876de58/fcell-12-1421981-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/95b8b63f33f7/fcell-12-1421981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/5a7aa34201f7/fcell-12-1421981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/225aaff2c3a3/fcell-12-1421981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/07103de4ae03/fcell-12-1421981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/3464765fb612/fcell-12-1421981-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2247/11408346/38240876de58/fcell-12-1421981-g006.jpg

相似文献

1
Evaluation of prognostic risk factors of triple-negative breast cancer with F-FDG PET/CT parameters, clinical pathological features and biochemical indicators.基于F-FDG PET/CT参数、临床病理特征及生化指标评估三阴性乳腺癌的预后危险因素
Front Cell Dev Biol. 2024 Sep 4;12:1421981. doi: 10.3389/fcell.2024.1421981. eCollection 2024.
2
Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [F]FDG PET/CT in Early Triple-Negative Breast Cancer.基线[F]FDG PET/CT的代谢、体积和纹理参数在早期三阴性乳腺癌中的预后价值
Cancers (Basel). 2022 Jan 27;14(3):637. doi: 10.3390/cancers14030637.
3
Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging.使用18F-FDG-PET/CT成像对三阴性乳腺癌预后进行分层。
Breast Cancer Res Treat. 2015 Oct;153(3):607-16. doi: 10.1007/s10549-015-3558-1. Epub 2015 Sep 7.
4
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.PET/CT上(18)F-FDG摄取与三阴性乳腺癌预后因素的相关性
Eur Radiol. 2015 Nov;25(11):3314-21. doi: 10.1007/s00330-015-3734-z. Epub 2015 Apr 23.
5
Pretreatment F-FDG Uptake Heterogeneity Predicts Treatment Outcome of First-Line Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer.预处理 F-FDG 摄取异质性可预测转移性三阴性乳腺癌一线化疗的治疗效果。
Oncologist. 2018 Oct;23(10):1144-1152. doi: 10.1634/theoncologist.2018-0001. Epub 2018 Aug 6.
6
The Value of Semiquantitative Parameters Derived from F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer.源自F-FDG PET/CT的半定量参数对不同分子亚型乳腺癌患者新辅助化疗反应的预测价值
Cancers (Basel). 2022 Nov 29;14(23):5869. doi: 10.3390/cancers14235869.
7
Metabolic Tumor Burden Assessed by Dual Time Point [F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.双时间点[F]FDG PET/CT评估局部晚期乳腺癌的代谢肿瘤负荷:与肿瘤生物学的关系
Mol Imaging Biol. 2017 Aug;19(4):636-644. doi: 10.1007/s11307-016-1034-x.
8
The prognostic value of F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases.移植前行 F-FDG PET/CT 对不可切除结直肠癌肝转移的预后价值。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):218-225. doi: 10.1007/s00259-017-3843-9. Epub 2017 Oct 12.
9
Predictive Ability of F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography for Pathological Complete Response and Prognosis after Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients.F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对三阴性乳腺癌患者新辅助化疗后病理完全缓解及预后的预测能力
Asia Ocean J Nucl Med Biol. 2016 Winter;4(1):3-11. doi: 10.7508/aojnmb.2016.04.002.
10
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.[(18)F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢参数作为接受放化疗的宫颈癌患者有用的预后因素
Radiat Oncol. 2016 Mar 16;11:43. doi: 10.1186/s13014-016-0614-x.

引用本文的文献

1
[18F]FDG PET/CT Radiomics in Untreated Breast Carcinoma: A Review of the Current State and Future Directions.[18F]氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在未经治疗的乳腺癌中的影像组学:现状与未来方向综述
Diagnostics (Basel). 2025 Sep 3;15(17):2231. doi: 10.3390/diagnostics15172231.

本文引用的文献

1
Prognostic Value of the F-FDG PET/CT and Haematological Parameters in Head and Neck Cancer.头颈部癌症中 F-FDG PET/CT 和血液学参数的预后价值。
Clin Otolaryngol. 2024 Nov;49(6):733-741. doi: 10.1111/coa.14195. Epub 2024 Jul 1.
2
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.预后标志物 KRT81 可抑制 CD8+T 细胞,并预测三阴性乳腺癌的免疫治疗反应。
Cancer Biol Ther. 2024 Dec 31;25(1):2355705. doi: 10.1080/15384047.2024.2355705. Epub 2024 May 22.
3
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
PET 放射组学在预测局部晚期宫颈癌的病理肿瘤反应和预后方面是否有用?
J Nucl Med. 2024 Jun 3;65(6):962-970. doi: 10.2967/jnumed.123.267044.
4
Construction and validation of an F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients.构建并验证基于 F-FDG-PET/CT 的预测初诊多发性骨髓瘤患者无进展生存期的预后模型。
Hematology. 2024 Dec;29(1):2329029. doi: 10.1080/16078454.2024.2329029. Epub 2024 Mar 15.
5
Preoperative low plasma creatine kinase levels predict worse survival outcomes in bladder cancer after radical cystectomy.术前低血浆肌酸激酶水平预示根治性膀胱切除术后膀胱癌患者的生存结局更差。
Int Urol Nephrol. 2024 Jul;56(7):2215-2225. doi: 10.1007/s11255-024-03957-2. Epub 2024 Feb 5.
6
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer.治疗前[18F]氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像([18F]FDG PET/CT)对预测乳腺癌预后的临床应用价值
J Clin Med. 2023 Aug 24;12(17):5487. doi: 10.3390/jcm12175487.
7
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.[18F]FDG PET/CT 预测新辅助化疗联合或不联合帕博利珠单抗治疗三阴性乳腺癌的结局。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4024-4035. doi: 10.1007/s00259-023-06394-y. Epub 2023 Aug 22.
8
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis.受体表达和临床亚型对乳腺癌基线[18F]FDG摄取的影响:系统评价和荟萃分析。
EJNMMI Res. 2023 Jan 23;13(1):5. doi: 10.1186/s13550-023-00953-y.
9
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.基因表达谱分析以发现三阴性乳腺癌早期诊断和治疗的分子特征。
Front Mol Biosci. 2022 Dec 7;9:1049741. doi: 10.3389/fmolb.2022.1049741. eCollection 2022.
10
Prognostic Value of Salivary Biochemical Indicators in Primary Resectable Breast Cancer.唾液生化指标在原发性可切除乳腺癌中的预后价值
Metabolites. 2022 Jun 16;12(6):552. doi: 10.3390/metabo12060552.